J. Goldman & Co LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,249,048
-20.5%
546,853
-1.0%
0.15%
-23.7%
Q2 2023$5,347,300
+702.5%
552,407
+808.6%
0.19%
+618.5%
Q1 2023$666,368
+122.9%
60,800
+350.4%
0.03%
+80.0%
Q3 2021$299,000
-79.1%
13,500
-86.1%
0.02%
-84.5%
Q3 2020$1,434,000
-64.3%
97,382
-60.6%
0.10%
-60.9%
Q2 2020$4,017,000
+87.5%
247,198
+67.5%
0.25%
-3.9%
Q1 2020$2,142,000
-30.7%
147,614
-3.2%
0.26%
+16.2%
Q4 2019$3,090,000152,5180.22%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders